Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cholangiocarcinoma × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 32 Neoplasms 5 Colorectal Neoplasms 3 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Neoplasm Metastasis 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 94 Cisplatin 62 Oxaliplatin 38 pembrolizumab 29 Fluorouracil 28 Capecitabine 27 durvalumab 24 Leucovorin 22 lenvatinib 21 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 pemigatinib 9 apatinib 9 Radiotherapy 9 Radiofrequency Ablation 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 8 Specimen Handling 8 Floxuridine 8 Bevacizumab 8 Folfox protocol 7 Carboplatin 7 Biopsy 7 tremelimumab 6 sintilimab 6 atezolizumab 6 Photochemotherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡